Xiaoyun Liu Selected Research

Ischemia

10/2021	Thymus quinquecostatus Celak. ameliorates cerebral ischemia-reperfusion injury via dual antioxidant actions: Activating Keap1/Nrf2/HO-1 signaling pathway and directly scavenging ROS.
1/2018	Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyun Liu Research Topics

Disease

30	Neoplasms (Cancer) 11/2023 - 03/2002
24	Infections 02/2024 - 08/2011
9	Major Depressive Disorder (Major Depressive Disorders) 11/2023 - 10/2010
9	Inflammation (Inflammations) 03/2023 - 01/2015
7	Ischemic Stroke 03/2024 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 07/2015
6	Fetal Growth Retardation (Intrauterine Growth Retardation) 09/2023 - 09/2021
5	Arthritis (Polyarthritis) 12/2023 - 08/2012
5	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 06/2015
4	Stroke (Strokes) 03/2024 - 01/2018
4	Bacterial Infections (Bacterial Infection) 01/2023 - 04/2017
4	Glioma (Gliomas) 10/2022 - 06/2019
3	Pain (Aches) 04/2024 - 12/2017
3	Epilepsy (Aura) 03/2024 - 01/2019
3	Pneumonia (Pneumonitis) 08/2023 - 02/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2023 - 01/2019
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 10/2015
3	Cerebral Infarction 01/2023 - 01/2021
3	Necrosis 01/2022 - 12/2010
3	Thyroiditis 01/2022 - 01/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2013
3	Graves Disease (Basedow Disease) 01/2022 - 01/2019
3	Reperfusion Injury 11/2021 - 01/2020
3	Thrombosis (Thrombus) 01/2021 - 01/2018
3	Starvation 01/2021 - 04/2018
3	Lung Neoplasms (Lung Cancer) 06/2020 - 10/2015
2	Stomach Neoplasms (Stomach Cancer) 12/2023 - 01/2018
2	Wounds and Injuries (Trauma) 12/2023 - 11/2021
2	Anhedonia 10/2023 - 06/2021
2	Osteoporosis 08/2023 - 01/2020
2	Periodontal Attachment Loss 08/2023 - 01/2023
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2023 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 09/2020
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2022 - 01/2011
2	Diabetes Mellitus 08/2022 - 01/2013
2	Insulin Resistance 08/2022 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2022 - 12/2014
2	Idiopathic Pulmonary Fibrosis 01/2022 - 11/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 11/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2019
2	Diarrhea 01/2022 - 01/2019
2	Thyroid Diseases (Thyroid Disease) 01/2022 - 01/2020
2	Anemia 01/2022 - 01/2021
2	Heart Failure 01/2022 - 11/2014
2	Brain Ischemia (Cerebral Ischemia) 10/2021 - 01/2020
2	Ischemia 10/2021 - 01/2018
2	Papillary Thyroid Cancer 02/2021 - 08/2018

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2007
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2015
7	Antidepressive Agents (Antidepressants)IBA 11/2023 - 01/2020
6	AntibodiesIBA 11/2023 - 02/2004
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2023 - 08/2012
5	CytokinesIBA 12/2023 - 01/2015
5	Messenger RNA (mRNA)IBA 12/2022 - 01/2016
5	Phosphotransferases (Kinase)IBA 12/2022 - 01/2012
5	Arginine (L-Arginine)FDA Link 12/2022 - 01/2020
5	Therapeutic UsesIBA 06/2021 - 01/2019
4	Type III Secretion SystemsIBA 11/2023 - 07/2017
4	CalciumIBA 01/2023 - 09/2015
4	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 06/2015
4	AntigensIBA 12/2022 - 03/2002
4	N-carbamylglutamateIBA 12/2022 - 09/2021
4	EnzymesIBA 10/2021 - 01/2014
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2016 - 08/2012
3	Kallikreins (Kallikrein)IBA 03/2024 - 06/2018
3	Virulence Factors (Pathogenicity Factors)IBA 11/2023 - 01/2017
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2023 - 01/2018
3	Oxygen (Dioxygen)IBA 01/2022 - 10/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021 - 04/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2018
3	ProteomeIBA 07/2020 - 08/2007
2	LigandsIBA 11/2023 - 01/2023
2	Estrogens (Estrogen)FDA Link 09/2023 - 03/2021
2	Immunoglobulins (Immunoglobulin)IBA 07/2023 - 08/2017
2	CateninsIBA 06/2023 - 10/2022
2	C-Reactive ProteinIBA 05/2023 - 01/2013
2	Endoplasmic Reticulum Chaperone BiPIBA 12/2022 - 01/2018
2	MelatoninIBA 06/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2020
2	Biocompatible Materials (Biomaterials)IBA 02/2022 - 12/2010
2	InterleukinsIBA 01/2022 - 01/2021
2	TrypsinIBA 01/2022 - 09/2014
2	AntioxidantsIBA 10/2021 - 03/2021
2	Circular RNAIBA 09/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 09/2021 - 06/2019
2	ChromatinIBA 08/2021 - 12/2018
2	FlavonoidsIBA 04/2021 - 03/2021
2	AcidsIBA 03/2021 - 04/2017
2	SteroidsIBA 03/2021 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2021 - 11/2018

Therapy/Procedure

18	Therapeutics 12/2023 - 06/2015
4	Drug Therapy (Chemotherapy) 01/2022 - 05/2017
3	Transplantation 01/2021 - 01/2019
3	Thyroidectomy 01/2016 - 11/2015
2	Traditional Medicine (Folk Remedies) 04/2024 - 10/2021
2	Immunotherapy 01/2023 - 01/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2022 - 06/2015
2	Radiotherapy 01/2022 - 01/2019
2	Punctures 01/2022 - 11/2020
2	Aftercare (After-Treatment) 01/2022 - 06/2021